Premphase and breast cancer in situ Patient Reports February 10, 2012

Premphase Side Effects Report #4947733-6
Premphase side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 02, 2006. Female patient, 50 years of age, weighting 180.2 lb, was diagnosed with menopause  and was treated with Premphase. After drug was administered, patient experienced the following side effects: breast cancer in situ, breast cancer metastatic, breast cancer recurrent. Premphase dosage: unknown. Patient was hospitalized. Patient recovered.

Premphase Side Effects Report #5308135-6
Premphase side effect was reported by a Consumer or non-health professional from UNITED STATES on Apr 16, 2007. Female patient, 49 years of age, weighting 126.0 lb, was diagnosed with menopausal symptoms and was treated with Premphase. After drug was administered, patient experienced the following side effects: bone density decreased, breast cancer in situ, breast cyst, breast mass, breast oedema, breast tenderness, cancer gene carrier, emotional distress, exostosis. Premphase dosage: unknown. During the same period patient was treated with ESTROGENS CONJUGATED W, ESTRADIOL, SYNTHROID, IMITREX, ESTRADERM, PREMPRO, PROVERA, PREMARIN. Patient recovered.

Premphase Side Effects Report #5520272-X
Premphase side effect was reported by a Consumer or non-health professional from UNITED STATES on Nov 13, 2007. Female patient, 49 years of age, weighting 126.0 lb, was diagnosed with menopausal symptoms and was treated with Premphase. After drug was administered, patient experienced the following side effects: arthralgia, bone density decreased, bone disorder, breast cancer in situ, breast cyst, breast mass, breast oedema, breast tenderness, cancer gene carrier. Premphase dosage: unknown. During the same period patient was treated with ESTROGENS CONJUGATED W, ESTRADIOL, SYNTHROID, IMITREX, ESTRADERM, PREMPRO, PROVERA, PREMARIN. Patient recovered.

Premphase Side Effects Report #5132197-2
Premphase side effect was reported by a Consumer or non-health professional from UNITED STATES on Oct 09, 2006. Female patient, 63 years of age, was treated with Premphase. After drug was administered, patient experienced the following side effects: breast cancer , breast cancer in situ, oestrogen receptor assay positive, progesterone receptor assay positive. Premphase dosage: unknown. During the same period patient was treated with PREMARIN, PROVERA. Patient recovered.


Premphase Side Effects Report #5027250-8
Premphase side effect was reported by a Consumer or non-health professional from UNITED STATES on May 30, 2006. Female patient, 59 years of age, weighting 162.1 lb, was treated with Premphase. After drug was administered, patient experienced the following side effects: breast cancer in situ, breast cancer metastatic, lung adenocarcinoma metastatic, metastases to lung, metastases to lymph nodes, necrosis, oestrogen receptor assay positive. Premphase dosage: unknown. During the same period patient was treated with CYCRIN, PREFEST, PREMARIN, PROVERA. Patient was hospitalized. Patient recovered.

Premphase Side Effects Report #5041482-4
Premphase side effect was reported by a Consumer or non-health professional from UNITED STATES on June 19, 2006. Female patient, 59 years of age, weighting 162.1 lb, was treated with Premphase. After drug was administered, patient experienced the following side effects: breast cancer in situ, breast cancer metastatic, breast cancer recurrent, lung adenocarcinoma, metastases to lung, metastases to lymph nodes, non-small cell lung cancer, oestrogen receptor assay positive, pneumothorax. Premphase dosage: unknown. During the same period patient was treated with CYCRIN, PREFEST, PREMARIN, PROVERA. Patient was hospitalized. Patient recovered.

Premphase Side Effects Report #5294221-6
Premphase side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 20, 2006. Female patient, 56 years of age, was treated with Premphase. After drug was administered, patient experienced the following side effects: breast cancer in situ. Premphase dosage: unknown. Patient recovered.

Premphase Side Effects Report #6075755-3
Premphase side effect was reported by a Consumer or non-health professional from UNITED STATES on Apr 28, 2008. Female patient, 52 years of age, was treated with Premphase. After drug was administered, patient experienced the following side effects: breast cancer in situ. Premphase dosage: unknown. During the same period patient was treated with PREMARIN, PROVERA. Patient recovered.

Premphase Side Effects Report #6077869-0
Premphase side effect was reported by a Consumer or non-health professional from UNITED STATES on Apr 28, 2008. Female patient, 52 years of age, was treated with Premphase. After drug was administered, patient experienced the following side effects: breast cancer in situ. Premphase dosage: unknown. During the same period patient was treated with PROVERA. Patient recovered.